PT906106E - Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca) - Google Patents

Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca) Download PDF

Info

Publication number
PT906106E
PT906106E PT97925934T PT97925934T PT906106E PT 906106 E PT906106 E PT 906106E PT 97925934 T PT97925934 T PT 97925934T PT 97925934 T PT97925934 T PT 97925934T PT 906106 E PT906106 E PT 906106E
Authority
PT
Portugal
Prior art keywords
colonic
prevention
treatment
fudca
microadenoma
Prior art date
Application number
PT97925934T
Other languages
English (en)
Inventor
Joyce Corey Gibson
Leonhard Robert Capuano
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT906106E publication Critical patent/PT906106E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PT97925934T 1996-05-23 1997-05-22 Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca) PT906106E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1820296P 1996-05-23 1996-05-23

Publications (1)

Publication Number Publication Date
PT906106E true PT906106E (pt) 2008-08-07

Family

ID=21786767

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97925934T PT906106E (pt) 1996-05-23 1997-05-22 Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca)

Country Status (10)

Country Link
US (1) US6426340B1 (pt)
EP (1) EP0906106B1 (pt)
JP (2) JP2000510858A (pt)
AT (1) ATE394107T1 (pt)
AU (1) AU3091597A (pt)
CA (1) CA2253593C (pt)
DE (1) DE69738667D1 (pt)
ES (1) ES2306459T3 (pt)
PT (1) PT906106E (pt)
WO (1) WO1997044043A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113785B1 (en) * 1998-07-24 2005-04-13 Seo Hong Yoo Clear aqueous solutions of bile acids
EP1105141B1 (de) * 1998-08-06 2003-11-05 Wolfgang Stremmel Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung
RS50303B (sr) * 1999-09-28 2009-09-08 Panacea Biotec Limited, Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
AU2003287300A1 (en) * 2002-11-01 2004-06-07 James Kaput Identification of diet-regulated disease-associated genes
US20090074785A1 (en) * 2007-01-16 2009-03-19 Smith Jeffrey W Compositions and methods for treatment of colorectal cancer
EP2255813A1 (en) * 2009-05-29 2010-12-01 The Royal College of Surgeons in Ireland Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
HUE030062T2 (en) 2010-11-08 2017-04-28 Albireo Ab IBAT inhibitors for the treatment of liver diseases
WO2015199147A1 (ja) 2014-06-25 2015-12-30 味の素株式会社 固形製剤及びその着色防止又は着色低減方法
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
EP3664781A1 (en) 2017-08-09 2020-06-17 Albireo AB Cholestyramine granules, oral cholestyramine formulations and use thereof
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
TW202015699A (zh) 2018-06-05 2020-05-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
BR112020024479A2 (pt) 2018-06-20 2021-03-02 Albireo Ab hidrato cristalino, modificações cristalinas de odevixibat, solvato misto de odevixibat, uso de modificação cristalina de odevixibat, processo para a preparação de modificação cristalina de odevixibat, e, composição farmacêutica
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
EP4069361B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CA3158184A1 (en) 2019-12-04 2021-08-10 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
DK4069360T3 (da) 2019-12-04 2024-02-26 Albireo Ab Benzothia(di)azepinforbindelser og anvendelse deraf som galdesyremodulatorer
ES2972045T3 (es) 2019-12-04 2024-06-10 Albireo Ab Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar
CN116157389A (zh) 2020-08-03 2023-05-23 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
EP4243831A1 (en) 2020-11-12 2023-09-20 Albireo AB Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
BR112023010799A2 (pt) 2020-12-04 2023-10-03 Albireo Ab Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8825526D0 (en) * 1988-11-01 1988-12-07 Enzymatix Ltd Diagnosis
US5175320A (en) * 1989-04-17 1992-12-29 Giuliani S.P.A. Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US5843929A (en) 1996-03-22 1998-12-01 Mayo Foundation For Medical Education And Research Chemoprevention of metachronous adenomatous colorectal polyps

Also Published As

Publication number Publication date
JP2010059175A (ja) 2010-03-18
CA2253593A1 (en) 1997-11-27
DE69738667D1 (de) 2008-06-19
ES2306459T3 (es) 2008-11-01
US6426340B1 (en) 2002-07-30
CA2253593C (en) 2008-07-08
AU3091597A (en) 1997-12-09
EP0906106B1 (en) 2008-05-07
JP2000510858A (ja) 2000-08-22
WO1997044043A1 (en) 1997-11-27
ATE394107T1 (de) 2008-05-15
EP0906106A1 (en) 1999-04-07

Similar Documents

Publication Publication Date Title
PT906106E (pt) Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca)
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
BG102668A (en) Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
IL148127A0 (en) Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
EP0768885A4 (en) METHOD FOR INHIBITING CANCER METASTASE BY ORAL ADMINISTRATION OF A MODIFIED SOLUBLE PECTIN OF CITRUS
IL124459A0 (en) Antagonists of gonadotropin releasing hormone
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
AU6147301A (en) Compositions and methods for the treatment of colorectal cancer
GEP20043383B (en) Cell Adhesion-Inhibiting Antiinflammatory and Immune-Suppressive Compounds
ZA967880B (en) Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
MY121623A (en) Methods of preventing breast cancer.
CA2186867A1 (en) Methods of Using Iron Chelating Compounds to Reduce Free Radical Damage in Mammals
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
WO2001037784A3 (en) Method for preventing irinotecan induced diarrhea
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
WO1995005364A3 (en) Inhibitors of biogenic amine transporters
WO2000010590A3 (en) Cancer treatment
IL126158A0 (en) Method for treating substance abuse
WO2001040241A3 (en) 6-o-alkyl-2-nor-2-substituted ketolide derivatives
DK1019066T3 (da) Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand
BG106831A (en) Compound and method for the treatment of pain
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
TR200102262T2 (tr) Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem.